Inhibiting autophagy-related apoptosis by Cathepsin S has been proven as an effective therapeutic strategy for glioma through inhibition of PI3K/AKT/mTOR/p70S6K signaling pathway and activation of JNK signaling pathway [17]. This evidence concerns the gene AKT1 and central nervous system cancer.